Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy
- PMID: 9607375
- DOI: 10.1016/s0895-7061(97)00492-5
Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy
Abstract
Diuretic-based therapy is less effective in reducing the cardiac complications of hypertension than the risk of stroke and may be less effective in reducing left ventricular (LV) mass than is therapy with angiotensin converting enzyme (ACE) inhibition. In view of the strong association of LV hypertrophy with cardiovascular risk, this study was designed to compare the impact of therapy with a diuretic and ACE inhibition on cardiac and vascular structure. Fifty essential hypertensives (74% male, 88% nonwhite) participated in a double-blind study for 6 months and were randomized to either ramipril or hydrochlorothiazide (HCTZ). Echocardiography, carotid ultrasonography, and ambulatory blood pressure (BP) monitoring were performed at baseline and 3 and 6 months after initiation of therapy. The 22 ramipril patients were comparable to the 28 HCTZ patients at baseline in age, race, and 24-h BP. Although HCTZ resulted in a greater reduction in 24-h BP, only treatment with ramipril resulted in a decrease in LV mass (193 to 179 g, P < .005, v 184 to 182 g, P = NS), attributable to a reduction in wall thicknesses but not in chamber diameter. In multivariate analysis, both change in BP and treatment group were independent predictors of change in LV mass. Importantly, although neither drug reduced carotid artery cross-sectional area, relative wall thickness increased due to a tendency for vessel diameter to decrease and wall thickness to increase, particularly in the diuretic group. Ramipril caused a sustained fall in plasma angiotensin II, whereas HCTZ increased angiotensin II levels. Although diuretic therapy was more effective in lowering ambulatory BP in this predominantly nonwhite population, only therapy with ACE inhibition was associated with regression of LV mass. Vascular geometry was altered consistent with the reduction in distending pressure resulting in vascular remodelling.
Similar articles
-
Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.J Hum Hypertens. 2008 Aug;22(8):559-68. doi: 10.1038/jhh.2008.26. Epub 2008 May 8. J Hum Hypertens. 2008. PMID: 18463672 Clinical Trial.
-
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.Hypertension. 2007 Feb;49(2):276-84. doi: 10.1161/01.HYP.0000253780.36691.4f. Epub 2006 Dec 11. Hypertension. 2007. PMID: 17159081 Clinical Trial.
-
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.J Hypertens. 2014 Oct;32(10):2038-44; discussion 2044. doi: 10.1097/HJH.0000000000000280. J Hypertens. 2014. PMID: 24983187 Clinical Trial.
-
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.Adv Ther. 2017 Apr;34(4):784-798. doi: 10.1007/s12325-017-0497-8. Epub 2017 Mar 4. Adv Ther. 2017. PMID: 28260186 Free PMC article. Review.
-
Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.J Hypertens. 2018 Jun;36(6):1247-1255. doi: 10.1097/HJH.0000000000001691. J Hypertens. 2018. PMID: 29465713
Cited by
-
First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.J Hum Hypertens. 2018 Jul;32(7):494-506. doi: 10.1038/s41371-018-0066-x. Epub 2018 May 1. J Hum Hypertens. 2018. PMID: 29713053
-
Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: A network meta-analysis of randomized controlled trials.J Clin Hypertens (Greenwich). 2020 Dec;22(12):2175-2183. doi: 10.1111/jch.14047. Epub 2020 Nov 15. J Clin Hypertens (Greenwich). 2020. PMID: 33190366 Free PMC article. Review.
-
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.JAMA. 2008 Apr 9;299(14):1678-89. doi: 10.1001/jama.299.14.1678. JAMA. 2008. PMID: 18398080 Free PMC article. Clinical Trial.
-
Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.Medicine (Baltimore). 2014 Nov;93(25):e130. doi: 10.1097/MD.0000000000000130. Medicine (Baltimore). 2014. PMID: 25437025 Free PMC article.
-
Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States?Curr Hypertens Rep. 2006 Jun;8(3):219-25. doi: 10.1007/s11906-006-0054-3. Curr Hypertens Rep. 2006. PMID: 17147920 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous